Feed/Investors/Sofinnova Partners through its Sofinnova Telethon Fund

Sofinnova Partners through its Sofinnova Telethon Fund

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2023-06-06

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$65.2M

across 1 round

LATEST ROUND

Series A · $65.2M · 2023-06-06

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
AAVantgarde AAVantgarde is a clinical-stage biotechnology company developing next-generation therapies for inherited retinal diseases with high unmet need	Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$65.2M	2023-06-06	[ PART ]